(RTTNews) - Quest Diagnostics (DGX) announced the launch of a new obstetrics laboratory test panel designed to enable physicians to screen all eligible pregnant people for hepatitis C with other ...

SECAUCUS, N.J., October 18, 2022 /CSRwire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, recently announced the launch of a new obstetrics ...

Quest Diagnostics launched an obstetrics test panel for screening pregnant people for hepatitis C. The panel is designed to facilitate easy and reliable screening for hepatitis C with other lab tests ...

Quest Diagnostics launched a new obstetrics test panel that is designed to allow physicians to easily test pregnant people for hepatitis C. The test panel screens for hepatitis C alongside other ...